Ovid Therapeutics Inc. ($OVID)
Filing Information
| Accession Number | 0002036798-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,446,656
Total Value
$16,901.20
P&L
+inf% (+$2,826,950.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 23, 2026 | Sale | 11,656 | $1.45 | $16,901.20 | 61,750 | Direct | โ | View Details | |
Director | Employee Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 1,435,000 | $0.00 | $0.00 | 1,435,000 | Direct | โ | View Details |